In Vitro and In Vivo Preclinical Testing of Pericyte‐Engineered Grafts for the Correction of Congenital Heart Defects

BACKGROUND: We have previously reported the possibility of using pericytes from leftovers of palliative surgery of congenital heart disease to engineer clinically certified prosthetic grafts. METHODS AND RESULTS: Here, we assessed the feasibility of using prosthetic conduits engineered with neonatal...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvino, Valeria Vincenza, Kilcooley, Michael, Thomas, Anita C., Carrabba, Michele, Fagnano, Marco, Cathery, William, Avolio, Elisa, Iacobazzi, Dominga, Ghorbel, Mohamed, Caputo, Massimo, Madeddu, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070228/
https://www.ncbi.nlm.nih.gov/pubmed/32067581
http://dx.doi.org/10.1161/JAHA.119.014214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070228/
https://www.ncbi.nlm.nih.gov/pubmed/32067581
http://dx.doi.org/10.1161/JAHA.119.014214

Ejemplares similares